All Stories

  1. The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence imm...

    Article • Epidemiology and Infection, March 2016, Cambridge University Press

    Dr Peter A Maple

  2. Varicella zoster immune status in children treated for acute leukemia

    Article • Pediatric Blood & Cancer, May 2014, Wiley

    Dr Peter A Maple

  3. Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England

    Article • Vaccine, February 2014, Elsevier

    Dr Peter A Maple

  4. Identification of Past and Recent Parvovirus B19 Infection in Immunocompetent Individuals by Quantitative PCR and Enzyme Immunoassays: a Dual-Laboratory Study

    Article • Journal of Clinical Microbiology, January 2014, ASM Journals

    Dr Peter A Maple

  5. Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers

    Article • Journal of Virological Methods, March 2011, Elsevier

    Dr Peter A Maple

  6. Persistence of varicella-zoster virus viraemia in patients with herpes zoster

    Article • Journal of Clinical Virology, February 2011, Elsevier

    Dr Peter A Maple

  7. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection

    Article • Journal of Virological Methods, April 2009, Elsevier

    Dr Peter A Maple

  8. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals

    Article • Journal of Virological Methods, February 2009, Elsevier

    Dr Peter A Maple

  9. Maternal HIV Infection and Placental Malaria Reduce Transplacental Antibody Transfer and Tetanus Antibody Levels in Newborns in Kenya

    Article • The Journal of Infectious Diseases, August 2007, Oxford University Press (OUP)

    Dr Peter A Maple

  10. Application of a noninvasive oral fluid test for detection of treponemal IgG in a predominantly HIV-infected population

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 2006, Springer Science + Business Media

    Dr Peter A Maple

  11. Performance of a Time-Resolved Fluorescence Immunoassay for Measuring Varicella-Zoster Virus Immunoglobulin G Levels in Adults and Comparison with Commercial Enzyme Immunoassays and Merck Glycoprotein Enzyme Immunoassay

    Article • Clinical and Vaccine Immunology, February 2006, ASM Journals

    Dr Peter A Maple

  12. An oral fluid test for syphilis

    Article • International Journal of STD & AIDS, April 2005, SAGE Publications

    Dr Peter A Maple

  13. Sero-epidemiology of Bordetella pertussis in England and Wales

    Article • Vaccine, March 2004, Elsevier

    Dr Peter A Maple

  14. European Sero-Epidemiology Network: standardisation of the assay results for pertussis

    Article • Vaccine, December 2003, Elsevier

    Dr Peter A Maple

  15. Time-resolved fluorometric immunoassay for rubella antibody—a useful method for serosurveillance studies

    Article • Vaccine, January 2002, Elsevier

    Dr Peter A Maple

  16. Novel methods for the detection of microbial antibodies in oral fluid

    Article • The Lancet Infectious Diseases, January 2002, Elsevier

    Dr Peter A Maple

  17. Time resolved fluorometric immunoassay, using europium labelled antihuman IgG, for the detection of human tetanus antitoxin in serum

    Article • Journal of Clinical Pathology, October 2001, BMJ

    Dr Peter A Maple

  18. Immunity to diphtheria and tetanus in England and Wales

    Article • Vaccine, September 2000, Elsevier

    Dr Peter A Maple

  19. European Sero-Epidemiology Network: standardisation of the results of diphtheria antitoxin assays

    Article • Vaccine, August 2000, Elsevier

    Dr Peter A Maple

  20. Diphtheria immunity in adults

    Article • The Lancet, October 1996, Elsevier

    Dr Peter A Maple

  21. Diphtheria immunity in UK blood donors

    Article • The Lancet, April 1995, Elsevier

    Dr Peter A Maple, Professor ANDROULLA EFSTRATIOU

  22. Antibiogram typing of methicillin-resistant staphylococcus aureus: A comparison with phage typing, biotyping and API Staph

    Article • Zentralblatt für Bakteriologie, July 1993, Elsevier

    Dr Peter A Maple

  23. Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.

    Article • Antimicrobial Agents and Chemotherapy, February 1991, ASM Journals

    Dr Peter A Maple

  24. WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

    Article • The Lancet, March 1989, Elsevier

    Dr Peter A Maple